Front. Mol. Neurosci. Frontiers in Molecular Neuroscience Front. Mol. Neurosci. 1662-5099 Frontiers Media S.A. 10.3389/fnmol.2022.865110 Molecular Neuroscience Correction Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood Guo Yuxin 1 2 Hu Zhiyuan 1 3 4 5 * Wang Zihua 3 * 1CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China 2University of Chinese Academy of Sciences, Beijing, China 3Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China 4School of Nanoscience and Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China 5School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Zhiyuan Hu huzy@nanoctr.cn Zihua Wang wangzh@fjmu.edu.cn

This article was submitted to Methods and Model Organisms, a section of the journal Frontiers in Molecular Neuroscience

 21 02 2022 2022 15 865110 29 01 2022 31 01 2022 Copyright © 2022 Guo, Hu and Wang. 2022 Guo, Hu and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood by Guo, Y., Hu, Z., and Wang, Z. (2021). Front. Mol. Neurosci. 14:778955. doi: 10.3389/fnmol.2021.778955 Alzheimer's disease blood biomarkers diagnosis peptide peptoid

In the published article, there was an error regarding the affiliations for Yuxin Guo. As well as having affiliation 1, they should also have “University of Chinese Academy of Sciences, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.